MyFinsight
Home
Blog
About
Contact
Back
Income Statement
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
source: myfinsight.com
Download
Download image
Net loss
-$94,391K
(-28.88%↓ Y/Y)
Interest income
$8,243K
(-12.03%↓ Y/Y)
Loss from operations
-$92,723K
(-16.91%↓ Y/Y)
Interest expense
$7,819K
(137.15%↑ Y/Y)
Product revenue, net
$311,337K
(126.84%↑ Y/Y)
Other expense, net
-$2,092K
Total operating
expenses
$404,060K
(86.58%↑ Y/Y)
Selling, general and
administrative
$268,521K
(59.95%↑ Y/Y)
Research and development
$108,692K
(146.07%↑ Y/Y)
Cost of sales
$26,847K
(494.88%↑ Y/Y)
Back